[Should pulmonary embolism be treated with thrombolytic agents?].
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011652:Pulmonary Circulation / Q000187:drug effects; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000401:mortality; D012306:Risk; D013300:Streptokinase / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Faut-il traiter les embolies pulmonaires par les thrombolytiques?